Vaccine patent row flares as factories seek shared blueprints
Across continents governments and WHO urge large pharma to share vaccine know-how to speed up production. Critics warn piecemeal licensing leaves poorer nations to pay more while rich countries stockpile doses. Calls grow for a global patent pool or temporary IP suspension to meet urgent demand.
MENTIONED IN THIS ARTICLE
Paris
Bangladesh
Germany
Associated Press
Britain
European Union
U.S
Pfizer
Moderna
AstraZeneca
Africa
Southeast Asia
World Health Organization
Europe
Abdul Muktadir
Incepta
WHO
South Africa
Mexico
Brazil
Uganda
Winnie Byanyima
Unaids
World Trade Organization
United States
African Union
COVAX
Ursula van der Leyen
European Commission
WTO
Nigeria
Ngozi Okonjo-Iweala
Albert Bourla
Thomas Cueni
International Federation of Pharmaceutical Manufacturers
Mustaqeem de Gama
Paul Fehlner
Biotech
Axcella
WHO Patent Pool Board
Anthony Fa
Suhaib Siddiqi
Siddiqi
Stéphane Bancel
Muktadir
Lawmakers Push Virus Misinformation Across State Legislatures
Republican lawmakers in several states spread false virus claims during hearings and on social platforms. Ohio YouTube removed a committee video after a witness claimed COVID-19 did not kill children. Idaho and Alaska debates featured vaccine skepticism and anti government rhetoric.
MENTIONED IN THIS ARTICLE
Columbus
YouTube
Ohio House
Ben Wizner
Aclu Speech, Privacy, and Technology Project
Hole
Wizner
Michigan
House Oversight Committee
Gretchen Whitmer
Jayme McElvany
Donald Trump
McElvany
Steven Johnson
State Health Department
Whitmer
Google
Tennessee
Bud Hussey
Hussey
Sabi Kumar
Kumar
Hassey
Hulsey
United States
House
Alaska
Mike Dunleavy
Lora Reinbold
Senate Judiciary Committee
Dunleavy
Reinbold
Senate
Idaho
Heather Scott
Scott
National Governors Association
World Economic Forum
COVID
Trump